Special Gazette, 27 February 2024

Contents

• Neomycin reconsideration – proposed decisions on reconsideration – 1
• Attachment A: Product registration(s) and label approval(s) placed under reconsideration – 3
• Attachment B: Statement of Reasons – 4
• Attachment C: Information on which the reasons are based – 33
• Attachment D: Proposed varied labels for neomycin chemical products – 35